canertinib dihydrochloride has been researched along with Lung Neoplasms in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Vandré, DD; Weitzel, DH | 1 |
| Balcerzak, SP; Galloway, S; Kraut, EH; Moore, T; Thomas, JP; Vandre, DD | 1 |
1 trial(s) available for canertinib dihydrochloride and Lung Neoplasms
| Article | Year |
|---|---|
A phase II study of CI-980 in previously untreated extensive small cell lung cancer: an Ohio State University phase II research consortium study.
Topics: Adult; Aged; Antineoplastic Agents; Carbamates; Carcinoma, Small Cell; Female; Humans; Leukocyte Count; Lung Neoplasms; Male; Middle Aged; Neoplasm Metastasis; Neutrophils; Pyrazines; Pyridines | 2002 |
1 other study(ies) available for canertinib dihydrochloride and Lung Neoplasms
| Article | Year |
|---|---|
Differential spindle assembly checkpoint response in human lung adenocarcinoma cells.
Topics: Adenocarcinoma; Antineoplastic Agents; Apoptosis; Carbamates; Fluorescent Antibody Technique, Indirect; Giant Cells; Humans; Lung Neoplasms; Microtubules; Mitosis; Pyrazines; Pyridines; Spindle Apparatus; Tumor Cells, Cultured | 2000 |